Medexus Pharmaceuticals Inc (MEDXF: OTCQX International) | Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update
$MEDXFOTCMarkets Syndication

Medexus Pharmaceuticals Inc (MEDXF: OTCQX International) | Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update

Syndication Releases
By Syndication Releases
0 Min Read



Medexus Pharmaceuticals Inc (MEDXF: OTCQX International) | Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update

Source link

#Medexus #Pharmaceuticals #MEDXF #OTCQX #International #Medexus #Announces #FDA #Approval #GRAFAPEX #treosulfan #Injection #Business #Update

Click here to Submit Your First Free Press Release – https://bit.ly/40HakT3

You Might Also Like

Hop-on, Inc. (HPNN: Pink Current) | Digitalage Set to Launch SocialSafe: A Lifeline for Content Creators Amidst US Ban TikTok Ban

Guardian Metal Resources PLC (GMTLF: OTCQX International) | Guardian Metal Resources PLC Announces Significant Porphyry South Copper Results

Hollywall Entertainment Inc. (HWAL: Pink Current) | Hollywall Entertainment, Inc (HWAL) subsidiary Melody Trust Launches Sync Music Licensing Partnership with Rival

FTAC Emerald Acquisition Corp. (FLDD: OTCQB) | Fold, Inc. and FTAC Emerald Acquisition Corp. Announce Effectiveness of Registration Statement and Special Meeting to Approve Business Combination

Canandaigua National Corp. (CNND: OTC Link) | Ex-Dividend

TAGGED:
Share This Article
Leave a Comment

Please Login to Comment.